PIUR IMAGING Secures €65M in Series B to Revolutionize Thyroid Diagnostics with AI-Driven 3D Ultrasound

PIUR IMAGING GmbH, an innovative Austrian medtech company specializing in the acquisition and visualization of 3D ultrasound images, has just announced a groundbreaking funding round, raising 65,000,000 to accelerate its mission of providing accessible, high-quality healthcare worldwide. This significant capital infusion will empower PIUR IMAGING to expand its trailblazing portfolio, including its flagship product, PIUR tUS Infinity—a tomographic ultrasound solution that transforms any standard ultrasound system into a powerful 3D imaging device. By harnessing the potential of artificial intelligence, PIUR tUS Infinity enables high-resolution, tomographic imaging with conventional 2D ultrasound transducers, allowing healthcare professionals to generate comprehensive 3D volumes that facilitate retrospective diagnoses and reduce the reliance on immediate, on-the-spot assessments. The solution stands out as the only vendor-independent platform explicitly designed to improve thyroid diagnostics by incorporating smart analysis tools that reduce operator dependency and enhance workflow efficacy in evaluating thyroid nodules and related structures. With this new funding, PIUR IMAGING is poised to further its vision of democratizing access to affordable, high-quality healthcare by scaling its AI-driven tomographic ultrasound technologies globally. The investment will support critical research and development efforts, drive strategic partnerships, and facilitate broader market penetration, ultimately making advanced diagnostic tools available in diverse clinical settings. Through this commitment, PIUR IMAGING continues to redefine the diagnostic capabilities of ultrasound imaging, pushing the boundaries of what is possible in medical diagnostics today, and ensuring that innovative healthcare solutions are within reach for all.